From: Innate immunity against HIV: a priority target for HIV prevention research
Stage of infection | Beneficial effects | Detrimental effects |
---|---|---|
HIV transmission | SLPI, Elafin and defensins help to block HIV infection | SEVI and WFDC-1 enhance HIV infection |
Establishment of initial foci of infection | Langerhans cells capture and destroy HIV virions Type 1 IFNs block HIV replication via upregulation of APOBECs and restriction factors | cDCs and macrophages act as sites for HIV replication and attract plus transmit infection to CD4+ T cells Local production of pro-inflammatory cytokines drives immune activation, enhancing viral replication |
Local virus replication and spread to draining lymph nodes | Type 1 IFNs continue to limit HIV replication Locally-recruited innate effector cells combat virus replication | Proinflammatory cytokines, type 1 IFNs and WFDC-1 promote local immune activation, enhancing virus replication DC-SIGN+ DCs carry HIV to lymph nodes and infect CD4+ T cells |
Further viral amplification and systemic dissemination | DCs activate innate effector cells including NK and NKT cells and begin to induce HIV-specific T cell responses NK, NKT and other innate effector cells combat HIV replication | cDCs and macrophages promote HIV transmission to CD4+ T cells DCs preferentially infect HIV-specific CD4+ T cells Immune activation mediated by pDCs and cDCs enhances HIV replication |
Exponential virus growth and depletion of central memory CD4+ T cells | HIV replication is combated by type 1 IFNs, NK and NKT cells DCs promote induction of adaptive responses | Immune activation mediated by DCs, NK cells and NKT cells enhances HIV replication |
Ongoing virus replication | Soluble innate factors and NK cells contribute to control of virus replication DCs help to sustain adaptive responses | cDCs and macrophages continue to promote HIV transmission to CD4+ T cells Immune activation mediated by DCs, NK cells and NKT cells enhances HIV replication |